As FDA staffing shortages and regulatory hurdles slow drug approvals, Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life, reveals how cutting-edge artificial intelligence (AI) technologies are ...
BOSTON--(BUSINESS WIRE)--Ora, Inc., the world’s leading partner for ophthalmic pharmaceutical and device development, announced today that David P. Bingaman, DVM, PhD, D. ACVO has joined the company ...
Funding cuts for research intended to make treatment and cures available and accessible for patients with HIV could affect HIV care in the long term. Patrick Sullivan, DVM, PhD, an infectious disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results